There are only limited data in the literature, and none specifically from the Middle East, on the pathogenic bacteria in chronic rhinosinusitis (CRS) as opposed to healthy nasal cavities and their association with disease severity. The present study was conducted in the department of head and neck surgery of a tertiary medical center. Middle meatal swabs were taken preoperatively from patients with CRS with nasal polyposis (CRSwNP) (n = 60), CRS without nasal polyposis (CRSsNP) (n = 50), and control patients with septal deviation (n = 26) or no nasal abnormalities (n = 27). Culture findings were compared among the groups and correlated with CRS severity. Positive pathogenic culture rates were 78% in the CRSwNP group and 64% in the CRSsNP group. Twenty pathogenic bacterial species were identified; the most common was Staphylococcus aureus (27%). The most common Gram-negative isolate was Citrobacter spp. (17%). Gram-negative species were significantly more prevalent in the CRSwNP group than the others. Mean Lund-Mackay scores were 12.8 in the CRSwNP group and 6.9 in the CRSsNP group, and were unrelated to the culture findings. Positive culture rates were significantly higher in the septal deviation (54%) than the nasal healthy group (26%), although both values were significantly lower than in the CRS groups. In conclusion, patients with CRS have higher rates of bacterial isolates than patients without CRS. CRSwNP is associated with more Gram-negative bacteria than CRSsNP, regardless of disease severity. The relatively high positive culture rate in patients with septal deviation merits investigation.

Keywords:
Nasal polyposis, Chronic rhinosinusitis, Bacteria, Sinus surgery, Septoplasty, Culture
1.
Kennedy JL, Borish L: Chronic rhinosinusitis and antibiotics: the good, the bad, and the ugly. Am J Rhinol Allergy 2013;27:467-472.
2.
Chaaban MR, Walsh EM, Woodworth BA: Epidemiology and differential diagnosis of nasal polyps. Am J Rhinol Allergy 2013;27:473-478.
3.
Rosenfeld RM, Andes D, Bhattacharyya N, Cheung D, et al: Clinical practice guideline: adult sinusitis. Otolaryngol Head Neck Surg 2007;137:S1-S31.
4.
Fokkens W, Lund V, Mullol J; European Position Paper on Rhinosinusitis and Nasal Polyps group: European position paper on rhinosinusitis and nasal polyps 2007. Rhinology 2007;20:S1-S136.
5.
Rontal M, Bernstein JM, Rontal E, Anon J: Bacteriologic findings from the nose, ethmoid, and bloodstream during endoscopic surgery for chronic rhinosinusitis: implications for antibiotic therapy. Am J Rhinol 1999;13:91-96.
6.
Bucholtz GA, Salzman SA, Bersalona FB, et al: PCR analysis of nasal polyps, chronic sinusitis, and hypertrophied turbinates for DNA encoding bacterial 16S rRNA. Am J Rhinol 2002;16:169-173.
7.
Brook I: Microbiology of sinusitis. Proc Am Thorac Soc 2011;8:90-100.
8.
Sinus and Allergy Health Partnership (SAHP): Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Otolaryngol Head Neck Surg 2004;130(suppl):S1-S45.
9.
Dubin MG, Liu C, Lin SY, Senior BA: American Rhinologic Society member survey on ‘maximal medical therapy' for chronic rhinosinusitis. Am J Rhinol 2007;21:483-488.
10.
Brook I, Frazier EH, Foote PA: Microbiology of the transition from acute to chronic maxillary sinusitis. J Med Microbiol 1996;45:372-375.
11.
Uhliarova B, Karnisova R, Svec M, Calkovska A: Correlation between culture-identified bacteria in the middle nasal meatus and CT score in patients with chronic rhinosinusitis. J Med Microbiol 2014;63:28-33.
12.
Niederfuhr A, Kirsche H, Riechelmann H, Wellinghausen N: The bacteriology of chronic rhinosinusitis with and without nasal polyps. Arch Otolaryngol Head Neck Surg 2009;135:131-136.
13.
Clark DW, Wenaas A, Citardi MJ, Luong A, Fakhri S: Chronic rhinosinusitis with nasal polyps: elevated serum immunoglobulin E is associated with Staphylococcus aureus on culture. Int Forum Allergy Rhinol 2011;1:445-445.
14.
Liu Q, Lu X, Bo M, Qing H, Wang X, Zhang L: The microbiology of chronic rhinosinusitis with and without nasal polyps. Acta Otolaryngol 2014;134:1251-1258.
15.
Busaba NY, Siegel NS, Salman SD: Microbiology of chronic ethmoid sinusitis: is this a bacterial disease? Am J Otolaryngol 2004;25:379-384.
16.
Lund VJ, Kennedy DW: Quantification for staging sinusitis. The Staging and Therapy Group. Ann Otol Rhinol Laryngol Suppl 1995;167:17-21.
17.
Brook I, Thompson D, Frazier E: Microbiology and management of chronic maxillary sinusitis. Arch Otolaryngol Head Neck Surg 1994;120:1317-1320.
18.
Bolger, William E: Gram negative sinusitis: an emerging clinical entity? Am J Rhinol 1994;8:279-284.
19.
Piromchai P, Kasemsiri P, Laohasiriwong S, Thanaviratananich S: Chronic rhinosinusitis and emerging treatment options. Int J Gen Med 2013;6:453-464.
20.
Russell PT, Bekeny JR: Oral antibiotics and the management of chronic sinusitis: what do we know? Curr Opin Otolaryngol Head Neck Surg 2014;22:22-26.
21.
Nadel DM, Lanza DC, Kennedy DW: Endoscopically guided cultures in chronic sinusitis. Am J Rhinol 1998;12:233-241.
22.
Kim HJ, Lee K, Yoo JB, Song JW, Yoon JH: Bacteriological findings and antimicrobial susceptibility in chronic sinusitis with nasal polyp. Acta Otolaryngol 2006;126:489-497.
23.
Brook I, Frazier EH: Bacteriology of chronic maxillary sinusitis associated with nasal polyposis. J Med Microbiol 2005;54:595-597.
24.
Jousimies-Somer HR, Savolainen S, Ylikoski JS: Comparison of the nasal bacterial floras in two groups of healthy subjects and in patients with acute maxillary sinusitis. J Clin Microbiol 1989;27:2736-2743.
25.
Brook I, Foote PA, Hausfeld JN: Increase in the frequency of recovery of methicillin-resistant Staphylococcus aureus in acute and chronic maxillary sinusitis. J Med Microbiol 2008;57:1015-1017.
26.
Manarey CR, Anand VK, Huang C: Incidence of methicillin-resistant Staphylococcus aureus causing chronic rhinosinusitis. Laryngoscope 2004;114:939-941.
27.
Rom D, Snidvongs K, Sacks PL, et al: The impact of culturable bacterial community on histopathology in chronic rhinosinusitis. Int Forum Allergy Rhinol 2014;4:23-33.
28.
Schlosser RJ, London SD, Gwaltney JM Jr, Gross CW: Microbiology of chronic frontal sinusitis. Laryngoscope 2001;111:1330-1332.
29.
Kremer B, Jacobs JA, Soudijn ER, van der Ven AJ: Clinical value of bacteriological examinations of nasal and paranasal mucosa in patients with chronic sinusitis. Eur Arch Otorhinolaryngol 2001;258:220-225.
30.
Savolainen S, Ylikoski J, Jousimies-Somer H: The bacterial flora of the nasal cavity in healthy young men. Rhinology 1986;24:249-255.
31.
Klossek JM, Dubreuil L, Richet H, Richet B, Sedallian A, Beutter P: Bacteriology of the adult middle meatus. J Laryngol Otol 1996;110:847-849.
32.
Nadel DM, Lanza DC, Kennedy DW: Endoscopically guided sinus cultures in normal subjects. Am J Rhinol 1999;13:87-90.
33.
Walgama E, Thanasumpun T, Gander R, Batra PS: Comparison of endoscopically-guided swab vs aspirate culture techniques in post-endoscopic sinus surgery patients: blinded, prospective analysis. Int Forum Allergy Rhinol 2013;3:726-730.
34.
Dubin MG, Ebert CS, Coffey CS, Melroy CT, Sonnenburg PE, Senior BA: Concordance of middle meatal swab and maxillary sinus aspirate in acute and chronic sinusitis: a meta-analysis. Am J Rhinol 2005;19:462-470.
35.
Boase S, Foreman A, Cleland E, et al: The microbiome of chronic rhinosinusitis: culture, molecular diagnostics and biofilm detection. BMC Infect Dis 2013;13:210.
36.
Hauser LJ, Feazel LM, Ir D, Fang R, Wagner BD, Robertson CE, Frank DN, Ramakrishnan VR: Sinus culture poorly predicts resident microbiota. Int Forum Allergy Rhinol 2015;5:3-9.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.